Skip to content
healthcare.dev

fondaparinux sodium

NDC 70710-1517, fondaparinux sodium, injection, solution, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
70710-1517
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208615
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1517 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FONDAPARINUX SODIUM10 mg/.8mL

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
70710-1517-67071015170610 SYRINGE in 1 CARTON (70710-1517-6) / .8 mL in 1 SYRINGE (70710-1517-2)
70710-1517-9707101517092 SYRINGE in 1 CARTON (70710-1517-9) / .8 mL in 1 SYRINGE (70710-1517-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dffbf7c9-495e-4a33-ac76-57b52f014fc2

Use it

Look up 70710-1517 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1517 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.